A detailed history of Evercore Wealth Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Evercore Wealth Management, LLC holds 785,229 shares of ABT stock, worth $91 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares
785,229
Previous 826,144 4.95%
Holding current value
$91 Million
Previous $85.8 Million 4.29%
% of portfolio
1.35%
Previous 1.35%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $4.09 Million - $4.83 Million
-40,915 Reduced 4.95%
785,229 $89.5 Million
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $2.22 Million - $2.48 Million
-22,030 Reduced 2.6%
826,144 $85.8 Million
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $402,814 - $444,890
3,678 Added 0.44%
848,174 $96.4 Million
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $373,386 - $457,056
-4,140 Reduced 0.49%
844,496 $93 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $179,118 - $214,912
1,875 Added 0.22%
848,636 $82.2 Million
Q2 2023

Aug 04, 2023

BUY
$100.78 - $112.29 $313,123 - $348,885
3,107 Added 0.37%
846,761 $92.3 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $130,276 - $153,343
1,345 Added 0.16%
843,654 $85.4 Million
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $75,382 - $88,435
793 Added 0.09%
842,309 $92.5 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $362,946 - $420,224
3,751 Added 0.45%
841,516 $81.4 Million
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $570,163 - $689,144
-5,586 Reduced 0.66%
837,765 $91 Million
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $352,549 - $429,911
3,092 Added 0.37%
843,351 $99.8 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $443,635 - $543,206
3,840 Added 0.46%
840,259 $118 Million
Q3 2021

Nov 15, 2021

SELL
$116.66 - $129.06 $291,533 - $322,520
-2,499 Reduced 0.3%
836,419 $98.8 Million
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $2.36 Million - $2.78 Million
22,291 Added 2.73%
838,918 $97.3 Million
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $1.11 Million - $1.3 Million
10,175 Added 1.26%
816,627 $97.9 Million
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $871,710 - $949,914
8,302 Added 1.04%
806,452 $88.3 Million
Q3 2020

Nov 16, 2020

BUY
$91.64 - $111.29 $813,030 - $987,364
8,872 Added 1.12%
798,150 $86.9 Million
Q2 2020

Aug 13, 2020

BUY
$76.57 - $98.0 $602,835 - $771,554
7,873 Added 1.01%
789,278 $72.2 Million
Q1 2020

May 14, 2020

BUY
$62.82 - $91.86 $2.1 Million - $3.07 Million
33,453 Added 4.47%
781,405 $61.7 Million
Q4 2019

Feb 13, 2020

BUY
$78.51 - $87.4 $1.79 Million - $1.99 Million
22,818 Added 3.15%
747,952 $65 Million
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $2.07 Million - $2.24 Million
25,246 Added 3.61%
725,134 $60.7 Million
Q2 2019

Aug 13, 2019

BUY
$72.88 - $85.0 $3.33 Million - $3.89 Million
45,736 Added 6.99%
699,888 $58.9 Million
Q1 2019

May 14, 2019

BUY
$66.22 - $80.06 $5.21 Million - $6.3 Million
78,647 Added 13.67%
654,152 $52.3 Million
Q4 2018

Feb 13, 2019

BUY
$65.56 - $74.27 $30.4 Million - $34.5 Million
464,293 Added 417.48%
575,505 $41.6 Million
Q3 2018

Nov 13, 2018

SELL
$60.81 - $73.36 $526,006 - $634,564
-8,650 Reduced 7.22%
111,212 $8.16 Million
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $67,299 - $74,278
1,169 Added 0.98%
119,862 $7.31 Million
Q1 2018

May 15, 2018

SELL
$56.27 - $63.62 $122,443 - $138,437
-2,176 Reduced 1.8%
118,693 $7.11 Million
Q4 2017

Feb 13, 2018

SELL
$53.68 - $57.47 $10,736 - $11,494
-200 Reduced 0.17%
120,869 $6.9 Million
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $5.82 Million - $6.49 Million
121,069
121,069 $6.46 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Evercore Wealth Management, LLC Portfolio

Follow Evercore Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evercore Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evercore Wealth Management, LLC with notifications on news.